Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
暂无分享,去创建一个
K. Leroy | H. Blons | F. Goldwasser | C. Tlemsani | M. Alifano | D. Damotte | M. Wislez | E. Giroux-Leprieur | A. Jouinot | N. Khoudour | B. Blanchet | A. Thomas-Schoemann | P. Boudou-Rouquette | M. Vidal | J. Alexandre | E. Fabre | J. Arrondeau | A. Mansuet-Lupo | M. Tiako Meyo | Etienne Giroux-Leprieur